Individuals with type 1 diabetes, thyroid cancer, multiple endocrine neoplasia, or end stage kidney disease at any time until cohort entry or individuals with dialysis or the latest eGFR 70 years, by males versus females, by insulin use, by atherosclerotic cardiovascular disease (i.e., myocardial infraction, angina, coronary artery disease, coronary revascularization, peripheral artery disease, aortic atherosclerotic disease, or cerebrovascular disease), by renal insufficiency (i.e., chronic kidney disease or the latest eGFR 70 years (HR [95% CI]: 0.95 [0.831.08])
FOR MAINS What are the side effects of GLP-1 drugs
Out-of-pocket costs for name-brand GLP-1 medications like Wegovy or Ozempic can soar above $1,300/month without coverage
The initial weeks of Wegovy treatment often represent a critical period for establishing new eating habits
If you want to treat clients hands-on, this course is the theory step - speak to admissions about the practical route that follows it